Clinical Trial Update: A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for BP1002 in advanced lymphoid malignancies across several B-cell and T-cell lymphomas; trial status is active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Cutaneous T-cell Lymphoma
• Follicular Lymphoma
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Peripheral T-cell Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• BP1002

Snippet

Sponsor: Bio-Path Holdings, Inc. | Conditions: Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL) | Phase 1 | Status: ACTIVE_NOT_RECRUITING